Carrageenans and antipeptic activity
Le Blond, J.; Denis, J.; Flouvat, B.
Annales Pharmaceutiques Francaises 31(3): 189-198
1973
ISSN/ISBN: 0003-4509 PMID: 4589934 Document Number: 67410
Document emailed within 1 workday
Related Documents
Anderson, W.; Harthill, J.E.; Zeitlin, I.J. 1984: Structure-activity in the carrageenans: iota-carrageenan and experimental oedemagenic activity Journal of Pharmacy and Pharmacology 36(12): 808-813Pawlaczyk, J.; Kokot, Z.; Rafińska, A. 1985: In vitro study of the antipeptic activity of antacid preparations Acta Poloniae Pharmaceutica 42(2): 153-158
Lietti, A.; Niada, R.; Prino, G. 1971: In vivo and in vitro antipeptic activity of a sulfate glycopeptide, degraded carrageenan and chondroitin sulfate Bollettino della Societa Italiana di Biologia Sperimentale 47(17): 493-497
D'Agostino, L.; Mazzacca, G. 1978: Treatment of peptic ulcer. Clinical-statistical evaluation of the effects of an antacid-antipeptic and contact anesthetic combination (Acidrine) Minerva Dietologica E Gastroenterologica 24(4): 349-352
Cudkowicz, G.; Yung, Y.P. 1977: Abrogation of resistance to foreign bone marrow grafts by carrageenans. I. Studies with the anti-macrophage agent seakem carrageenan Journal of Immunology 119(2): 483-487
Antonopoulos, A.; Herbreteau, B.; Lafosse, M.; Helbert, W. 2004: Comparative analysis of enzymatically digested kappa-carrageenans, using liquid chromatography on ion-exchange and porous graphitic carbon columns coupled to an evaporative light scattering detector Journal of Chromatography A 1023(2): 231-238
Ihle, J.N.; Keller, J.; Oroszlan, S.; Henderson, L.E.; Copeland, T.D.; Fitch, F.; Prystowsky, M.B.; Goldwasser, E.; Schrader, J.W.; Palaszynski, E.; Dy, M.; Lebel, B. 1983: Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity Journal of Immunology 131(1): 282-287
Gatzounis, R.; Schrooten, M.G.S.; Crombez, G.; Vlaeyen, J.W.S. 2018: Activity interruptions by pain impair activity resumption, but not more than activity interruptions by other stimuli: an experimental investigation Pain 159(2): 351-358
Vitali, C.; Bencivelli, W.; Isenberg, D.A.; Smolen, J.S.; Snaith, M.L.; Sciuto, M.; Neri, R.; Bombardieri, S. 1992: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE Clinical and Experimental Rheumatology 10(5): 541-547
Pal'chykovs'ka, L.H.; Aleksieieva, I.V.; Kostina, V.H.; Platonov, M.O.; Nehruts'ka, V.V.; Deriabin, O.M.; Tarasov, O.A.; Shved, A.D. 2008: New amides of phenazine-1-carboxylic acid: antimicrobial activity and structure-activity relationship Ukrains'kyi Biokhimichnyi Zhurnal 80(3): 140-147
Konstantinov, N.; Cheresharov, L.; Toshkova, S. 1979: Morphometric studies of the changes in reproductive activity of the rat ovaries in regimens of immobilization and motor activity Veterinarno-Meditsinski Nauki 16(6): 66-74
Stanković, S. 2001: X-rays in molecular biophysics: structure-activity relationships and activity of steroid hormones Medicinski Pregled 54(9-10): 413-421
Jaworkowsky, L.; Shilevitsch, A.; Priedniece, E.; Grant, H. 1980: The phagocytic activity (ingestion and bactericidal activity) of neutrophil leukocytes in chronic myelosis Folia Haematologica 107(2): 213-220
Tseng, L.F.; Loh, H.H. 1974: Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity Journal of Pharmacology and Experimental Therapeutics 189(3): 717-724
Cechinel Filho, V.; Pinheiro, T.; Nunes, R.J.; Yunes, R.A.; Cruz, A.B.; Moretto, E. 1994: Antibacterial activity of N-phenylmaleimides, N-phenylsuccinimides and related compounds. Structure-activity relationships Farmaco 49(10): 675-677
Garuti, L.; Ferranti, A.; Giovanninetti, G.; Baserga, M.; Mannini Palenzona, A. 1981: Research on a substance with antiviral activity. XXI. Preparation and antiherpes activity of 2-acylamino-3,5-dichloropyridine Il Farmaco; Edizione Scientifica 36(10): 862-866
Nowak, J.; Szafran, Z.; Grabczyńska-Amborska, H. 1982: Arylesterase activity and total serum esterolytic activity in infants with pneumonia Pediatria Polska 57(12): 1023-1027
Tomilina, I.V. 1977: Influence of the hippocampus on the luteinizing activity of the adenohypophysis and the contraceptive activity of megastranol Farmakologiia i Toksikologiia 40(3): 342-346
Yano, A.; Hashimoto, K.; Okuchi, T.; Mizoguchi, H.; Mutaguchi, K.; Nakamoto, T.; Usui, T. 2001: Dihydropyrimidine dehydrogenase activity in urothelial cancer--influence of UFT administration on DPD activity Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(12): 1877-1883
Bezákova, L.; Masterová, I.; Paulíková, I.; Psenák, M. 1996: Inhibitory activity of isorhamnetin glycosides from Calendula officinalis L. on the activity of lipoxygenase Die Pharmazie 51(2): 126-127